The role of probiotic bacteria in managing periodontal disease: a systematic review

Expert Review of Anti-Infective Therapy

Volumn 14, Issue 7, 2016, Pages 643-655

  Matsubara, Victor Haruo ^a,b   Bandara, H M H N ^a   Ishikawa, Karin Hitomi ^b   Mayer, Marcia Pinto Alves ^b   Samaranayake, Lakshman Perera ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

dental hygiene; inflammation; Lactobacillus; Periodontal diseases; periodontitis; probiotics; Streptococcus

Indexed keywords

PROBIOTIC AGENT;

ABSENCE OF SIDE EFFECTS; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; BIFIDOBACTERIUM; GINGIVA BLEEDING; HUMAN; LACTOBACILLUS; NONHUMAN; PATIENT COMPLIANCE; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; PREVOTELLA INTERMEDIA; PROBING POCKET DEPTH; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAFETY; STREPTOCOCCUS; SYSTEMATIC REVIEW; TREATMENT RESPONSE; DENTAL SCALING; DIETARY SUPPLEMENT; MULTIMODALITY CANCER THERAPY; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL POCKET; PERIODONTITIS; TREATMENT OUTCOME;

BIFIDOBACTERIUM; COMBINED MODALITY THERAPY; DENTAL SCALING; DIETARY SUPPLEMENTS; HUMANS; LACTOBACILLUS; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL POCKET; PERIODONTITIS; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84975217498     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1080/14787210.2016.1194198     Document Type: Review

References (57)

1. G.Hajishengallis Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol. 2015;15(1):30–44.
2. B.L.Pihlstrom, B.S.Michalowicz, N.W.Johnson. Periodontal diseases. Lancet. 2005;366(9499):1809–1820.
3. R.J.Genco, T.E.Van Dyke. Prevention: reducing the risk of CVD in patients with periodontitis. Nat Rev Cardiol. 2010;7(9):479–480.
4. P.N.Madianos, Y.A.Bobetsis, S.Offenbacher. Adverse pregnancy outcomes (APOs) and periodontal disease: pathogenic mechanisms. J Clin Periodontol. 2013;40(Suppl 14):S170–180.
5. S.S.Socransky, A.D.Haffajee. Periodontal microbial ecology. Periodontol 2000. 2005;38:135–187.• A state-of-the-art overview of the microbial eco-balance within the periodontium.
6. G.Hajishengallis, R.P.Darveau, M.A.Curtis. The keystone-pathogen hypothesis. Nat Rev Microbiol. 2012;10(10):717–725.
7. J.E.Suvan. Effectiveness of mechanical nonsurgical pocket therapy. Periodontol 2000. 2005;37:48–71.
8. H.C.Hung, C.W.Douglass. Meta-analysis of the effect of scaling and root planing, surgical treatment and antibiotic therapies on periodontal probing depth and attachment loss. J Clin Periodontol. 2002;29(11):975–986.
9. G.Gupta. Probiotics and periodontal health. J Med Life. 2011;4(4):387–394.
10. M.S.Tonetti, I.L.Chapple. Working Group 3 of Seventh European Workshop on Periodontology. Biological approaches to the development of novel periodontal therapies – consensus of the Seventh European Workshop on Periodontology. J Clin Periodontol. 2011;38(Suppl 11):114–118.
11. C.Hill, F.Guarner, G.Reid, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506–514.
12. J.H.Meurman, I.Stamatova. Probiotics: contributions to oral health. Oral Dis. 2007;13(5):443–451.
13. V.H.Matsubara, E.G.Silva, C.R.Paula, et al. Treatment with probiotics in experimental oral colonization by Candida albicans in murine model (DBA/2). Oral Dis. 2012;18(3):260–264.
14. S.Boris, J.E.Suárez, F.Vázquez, et al. Adherence of human vaginal lactobacilli to vaginal epithelial cells and interaction with uropathogens. Infect Immun. 1998;66(5):1985–1989.
15. H.Nikawa, S.Makihira, H.Fukushima, et al. Lactobacillus reuteri in bovine milk fermented decreases the oral carriage of mutans streptococci. Int J Food Microbiol. 2004;95(2):219–223.
16. M.Tekce, G.Ince, H.Gursoy, et al. Clinical and microbiological effects of probiotic lozenges in the treatment of chronic periodontitis: a 1-year follow-up study. J Clin Periodontol. 2015;42(4):363–372.•• One of the longest RCTs evaluating the effects of lozenges containing L. reuteri as an adjuvant treatment to periodontal therapy for chronic periodontitis.
17. W.Teughels, A.Durukan, O.Ozcelik, et al. Clinical and microbiological effects of Lactobacillus reuteri probiotics in the treatment of chronic periodontitis: a randomized placebo-controlled study. J Clin Periodontol. 2013;40(11):1025–1035.
18. N.Suzuki, K.Tanabe, T.Takeshita, et al. Effects of oil drops containing Lactobacillus salivarius WB21 on periodontal health and oral microbiota producing volatile sulfur compounds. J Breath Res. 2012;6(1):017106.
19. G.Rodríguez, B.Ruiz, S.Faleiros, et al. Probiotic compared with standard milk for high-caries children: a cluster randomized trial. JDR. 2016;95(4):402–407.
20. K.H.Ishikawa, M.P.Mayer, T.Y.Miyazima, et al. A multispecies probiotic reduces oral Candida colonization in denture wearers. J Prosthodont. 2015;24(3):194–199.
21. J.P.Burton, C.N.Chilcott, J.R.Tagg. The rationale and potential for the reduction of oral malodour using Streptococcus salivarius probiotics. Oral Dis. 2005;11(Suppl 1):29–31.
22. G.Ince, H.Gursoy, S.D.Ipci, et al. Clinical and biochemical evaluation of Lactobacillus reuteri containing lozenges as an adjunct to non-surgical periodontal therapy in chronic periodontitis. J Periodontol. 2015;86(6):746–754.•• A well-conducted RCT testing L. reuteri supplementation during the initial treatment phase of chronic periodontitis.
23. ®) alone, combination of probiotic with doxycycline and doxycycline alone on aggressive periodontitis – a clinical and microbiological study. J Clin Diagn Res. 2013;7(3):595–600.•• This RCT was the only study testing probiotic therapy against the aggressive form of periodontitis.
24. P.F.Chien, K.S.Khan, D.Siassakos. Registration of systematic reviews: PROSPERO. BJOG. 2012;119(8):903–905.
25. D.Moher, A.Liberati, J.Tetzlaff, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336–341.
26. J.P.T.Higgins, S.Green. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated 2011 Mar]. 2011. The Cochrane Collaboration. Available from: http://handbook.cochrane.org.
27. A.Morales, P.Carvajal, N.Silva, et al. Clinical effects of Lactobacillus rhamnosus in non-surgical treatment of chronic periodontitis: a randomized placebo-controlled trial with 1-year follow-up. J Periodontol. 2016;1–12. [Epub ahead of print]
28. I.Laleman, E.Yilmaz, O.Ozcelik, et al. The effect of a streptococci containing probiotic in periodontal therapy: a randomized controlled trial. J Clin Periodontol. 2015;42(11):1032–1041.
29. M.Vicario, A.Santos, D.Violant, et al. Clinical changes in periodontal subjects with the probiotic Lactobacillus reuteri Prodentis: a preliminary randomized clinical trial. Acta Odontol Scand. 2013;71(3–4):813–819.
30. M.R.Vivekananda, K.L.Vandana, K.G.Bhat. Effect of the probiotic Lactobacilli reuteri (Prodentis) in the management of periodontal disease: a preliminary randomized clinical trial. J Oral Microbiol. 2010;2:5344.•• This study demonstrated that probiotic bacteria, either alone or following mechanical treatment, significantly reduced periodontopathogens in chronic periodontitis.
31. G.Mayanagi, M.Kimura, S.Nakaya, et al. Probiotic effects of orally administered Lactobacillus salivarius WB21-containing tablets on periodontopathic bacteria: a double-blinded, placebo-controlled, randomized clinical trial. J Clin Periodontol. 2009;36(6):506–513.
32. H.Shimauchi, G.Mayanagi, S.Nakaya, et al. Improvement of periodontal condition by probiotics with Lactobacillus salivarius WB21: a randomized, double-blind, placebo-controlled study. J Clin Periodontol. 2008;35(10):897–905.
33. D.N.Della Riccia, F.Bizzini, M.G.Perilli, et al. Anti-inflammatory effects of Lactobacillus brevis (CD2) on periodontal disease. Oral Dis. 2007;13(4):376–385.
34. J.P.Higgins, D.G.Altman, P.C.Gotzsche, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. Bmj. 2011;343:d5928.
35. M.Quirynen, W.Teughels, M.De Soete, et al. Topical antiseptics and antibiotics in the initial therapy of chronic adult periodontitis: microbiological aspects. Periodontol 2000. 2002;28:72–90.
36. M.Feres, L.C.Figueiredo, G.M.Soares, et al. Systemic antibiotics in the treatment of periodontitis. Periodontol 2000. 2015;67(1):131–186.
37. L.Lehtoranta, A.Pitkäranta, R.Korpela. Probiotics in respiratory virus infections. Eur J Clin Microbiol Infect Dis. 2014;33(8):1289–1302.
38. R.Fuller. Probiotics in human medicine. Gut. 1991;32(4):439–442.
39. V.H.Matsubara, H.M.Bandara, M.P.Mayer, et al. Probiotics as antifungals in mucosal candidiasis. Clin Infect Dis. 2016 Jan 29;pii:ciw038. [Epub ahead of print].• A very recent review collating the clinical evidence on how probiotics ameliorate oral candidial infections.
40. A.Savage, K.A.Eaton, D.R.Moles, et al. A systematic review of definitions of periodontitis and methods that have been used to identify this disease. J Clin Periodontol. 2009;36(6):458–467.
41. H.Loe, J.Silness. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand. 1963;21:533–551.
42. J.Ainamo, I.Bay. Problems and proposals for recording gingivitis and plaque. Internat Dent J. 1975;25(4):229–235.
43. Kõll-Klais P, Mändar R, Leibur E, et al. Oral lactobacilli in chronic periodontitis and periodontal health: species composition and antimicrobial activity. Oral Microbiol Immunol. 2005;20(6):354–361.
44. H.Ishikawa, Y.Aiba, M.Nakanishi, et al. Suppression of periodontal pathogenic bacteria by the administration of Lactobacillus salivarius T12711. J Jap Soc Periodontol. 2003;45:105–112.
45. H.Lynch, P.Milgrom. Xylitol and dental caries: an overview for clinicians. J Calif Dent Assoc. 2003;31(3):205–209.
46. E.Park, H.S.Na, S.M.Kim, et al. Xylitol, an anticaries agent, exhibits potent inhibition of inflammatory responses in human THP-1-derived macrophages infected with Porphyromonas gingivalis. J Periodontol. 2014;85(6):e212–223.
47. S.J.Han, S.Y.Jeong, Y.J.Nam, et al. Xylitol inhibits inflammatory cytokine expression induced by lipopolysaccharide from Porphyromonas gingivalis. Clin Diagn Lab Immunol. 2005;12(11):1285–1291.
48. P.D.Marsh. Microbial ecology of dental plaque and its significance in health and disease. Adv Dent Res. 1994;8(2):263–271.
49. W.Teughels, G.Loozen, M.Quirynen. Do probiotics offer opportunities to manipulate the periodontal oral microbiota? J Clin Periodontol. 2011;38(Suppl 11):159–177.
50. M.S.Geier, R.N.Butler, G.S.Howarth. Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics. Int J Food Microbiol. 2007;115(1):1–11.
51. L.A.Dieleman, M.S.Goerres, A.Arends, et al. Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut. 2003;52(3):370–376.
52. F.Yan, D.B.Polk. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem. 2002;277(52):50959–50965.
53. L.Schaefer, T.A.Auchtung, K.E.Hermans, et al. The antimicrobial compound reuterin (3-hydroxypropionaldehyde) induces oxidative stress via interaction with thiol groups. Microbiology. 2010;156(Pt 6):1589–1599.
54. D.F.Kinane, I.B.Darby, S.Said, et al. Changes in gingival crevicular fluid matrix metalloproteinase-8 levels during periodontal treatment and maintenance. J Periodontal Res. 2003;38(4):400–404.
55. F.Daghigh, R.C.Borghaei, R.D.Thornton, et al. Human gingival fibroblasts produce nitric oxide in response to proinflammatory cytokines. J Periodontol. 2002;73(4):392–400.
56. K.Komine, T.Kuroishi, A.Ozawa, et al. Cleaved inflammatory lactoferrin peptides in parotid saliva of periodontitis patients. Mol Immunol. 2007;44(7):1498–1508.
57. M.Bernardeau, J.P.Vernoux, S.Henri-Dubernet, et al. Safety assessment of dairy microorganisms: the Lactobacillus genus. Int J Food Microbiol. 2008;126(3):278–285.